betaxolol has been researched along with Angiogranuloma in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data from a series of 35 non-small cell lung cancer cases suffering from EGFR inhibitor-induced paronychia with pyogenic granuloma-like lesions of digits treated with betaxolol 0." | 7.96 | Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study. ( Chi, CC; Chung, WH; Hsu, CK; Ko, YS; Lee, CN; Lu, CW; Pang, JS; Wang, CL; Wang, CW; Yang, HS; Yen, CF, 2020) |
| "Data from a series of 35 non-small cell lung cancer cases suffering from EGFR inhibitor-induced paronychia with pyogenic granuloma-like lesions of digits treated with betaxolol 0." | 3.96 | Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study. ( Chi, CC; Chung, WH; Hsu, CK; Ko, YS; Lee, CN; Lu, CW; Pang, JS; Wang, CL; Wang, CW; Yang, HS; Yen, CF, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dany, M | 1 |
| Yen, CF | 2 |
| Hsu, CK | 2 |
| Yang, HS | 1 |
| Lee, CN | 1 |
| Chi, CC | 1 |
| Chung, WH | 1 |
| Wang, CL | 1 |
| Pang, JS | 1 |
| Wang, CW | 1 |
| Ko, YS | 1 |
| Lu, CW | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitor-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study[NCT05165082] | 8 participants (Actual) | Interventional | 2021-12-21 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for betaxolol and Angiogranuloma
| Article | Year |
|---|---|
Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Betaxolol; Clinical Tr | 2019 |
2 other studies available for betaxolol and Angiogranuloma
| Article | Year |
|---|---|
Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study.
Topics: Administration, Topical; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Ant | 2020 |
Topical betaxolol for treating relapsing paronychia with pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors.
Topics: Administration, Topical; Afatinib; Betaxolol; ErbB Receptors; Female; Follow-Up Studies; Granuloma, | 2018 |